ABCL

3.86

2.66% 0.10

Dopo l'orario di chiusura: 3.85 -0.010 -0.26%

Abcellera Biologics Inc (ABCL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ABCL Giù? Forum Previsione

Precedente Chiudi:

$3.76

Aprire:

$3.77

Volume 24 ore:

2.98M

Relative Volume:

0.81

Capitalizzazione di mercato:

$1.17B

Reddito:

$75.13M

Utile/perdita netta:

$-146.41M

Rapporto P/E:

-7.8711

EPS:

-0.4904

Flusso di cassa netto:

$-174.43M

1 W Prestazione:

+12.54%

1M Prestazione:

+10.60%

6M Prestazione:

-36.72%

1 anno Prestazione:

+58.85%

Intervallo 1D:

$3.77

$3.90

Intervallo di 1 settimana:

$3.37

$3.90

Portata 52W:

$1.94

$6.515

Abcellera Biologics Inc Stock (ABCL) Company Profile

Nome

Abcellera Biologics Inc

Settore

Healthcare (1112)

Industria

Biotechnology (621)

Telefono

(604) 559-9005

Indirizzo

150 W 4TH AVENUE, VANCOUVER

Dipendente

562

Cinguettio

Prossima data di guadagno

2024-11-18

Ultimi documenti SEC

ABCL's Discussions on Twitter

Compare ABCL vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ABCL Abcellera Biologics Inc	3.86	1.14B	75.13M	-146.41M	-174.43M	-0.4904
VRTX Vertex Pharmaceuticals Inc	441.70	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	34.41B	5.36B	287.73M	924.18M	2.5229

Abcellera Biologics Inc Stock (ABCL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-11-07	Downgrade	Leerink Partners	Outperform → Market Perform
2025-07-07	Ripresa	Leerink Partners	Outperform
2024-08-20	Downgrade	The Benchmark Company	Buy → Hold
2024-02-22	Aggiornamento	The Benchmark Company	Hold → Buy
2023-12-05	Iniziato	KeyBanc Capital Markets	Overweight
2023-11-06	Downgrade	The Benchmark Company	Buy → Hold
2023-10-13	Ripresa	Piper Sandler	Overweight
2023-02-28	Iniziato	Cowen	Outperform
2022-12-15	Iniziato	Goldman	Buy
2022-11-16	Iniziato	Truist	Buy
2021-12-21	Iniziato	The Benchmark Company	Buy
2021-11-19	Iniziato	Piper Sandler	Overweight
2021-01-05	Iniziato	BMO Capital Markets	Outperform
2021-01-05	Iniziato	Berenberg	Buy
2021-01-05	Iniziato	Credit Suisse	Outperform
2021-01-05	Iniziato	SVB Leerink	Outperform
2021-01-05	Iniziato	Stifel	Buy

Mostra tutto

Abcellera Biologics Inc Borsa (ABCL) Ultime notizie

11:08 AM

Truist reiterates Buy on AbCellera stock, eyes 2H26 data readout By Investing.com - Investing.com Canada

11:08 AM

11:00 AM

Truist reiterates Buy on AbCellera stock ahead of 2H26 data - Investing.com

11:00 AM

10:56 AM

Truist reiterates Buy on AbCellera stock ahead of 2H26 data By Investing.com - Investing.com Canada

10:56 AM

10:54 AM

Truist reiterates Buy on AbCellera stock, eyes 2H26 data readout - Investing.com

10:54 AM

Apr 14, 2026

Biotech Penny Stocks Rally OABI ABCL PACB 2026 - Gotrade

Apr 14, 2026

Is Jones Trading’s New Coverage of AbCellera (ABCL) Reframing Its Clinical-Stage Platform Narrative? - Yahoo Finance

Apr 14, 2026

AbCellera Biologics (ABCL) Committed to Leverage Differentiated Technology for Drug Discovery - Insider Monkey

Apr 14, 2026

Apr 13, 2026

Is AbCellera Biologics Inc affected by consumer sentimentWall Street Watch & Free High Return Stock Watch Alerts - baoquankhu1.vn

Apr 13, 2026

Wall Street Bullish on AbCellera Biologics Inc. (ABCL), Here’s Why - MSN

Apr 13, 2026

Portfolio Recap: Is AbCellera Biologics Inc part of any ETFMarket Activity Summary & Precise Swing Trade Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 11, 2026

Insider Sell: What hedge funds are buying AbCellera Biologics Inc2026 Fundamental Recap & Fast Entry High Yield Stock Tips - baoquankhu1.vn

Apr 11, 2026

AbCellera Biologics Inc (HAM:8QQ) Stock Price & 30 Year Financial Data - GuruFocus

Apr 11, 2026

Apr 10, 2026

AbCellera Biologics (ABCL): New 'Buy' Rating from Jones Trading | ABCL Stock News - GuruFocus

Apr 10, 2026

Jones Trading initiates coverage of AbCellera Biologics (ABCL) with buy recommendation - MSN

Apr 10, 2026

Apr 09, 2026

JonesTrading Initiates AbCellera Biologics(ABCL.US) With Buy Rating, Announces Target Price $11 - Moomoo

Apr 09, 2026

ABCL News | ABCELLERA BIOLOGICS INC (NASDAQ:ABCL) - ChartMill

Apr 09, 2026

Apr 07, 2026

Aug Big Picture: What is AbCellera Biologics Incs P E ratio telling usTrade Ideas & Accurate Buy Signal Notifications - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026

Insider Stock Buying Reaches US$1.04m On AbCellera Biologics - Moomoo

Apr 06, 2026

Truist Financial Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Announces Target Price $3.52 - Moomoo

Apr 06, 2026

Press Releases about AbCellera Biologics Inc.Common Shares (Nasdaq:ABCL) - FinancialContent

Apr 06, 2026

ABCL Technical Analysis | Trend, Signals & Chart Patterns | ABCELLERA BIOLOGICS INC (NASDAQ:ABCL) - ChartMill

Apr 06, 2026

Apr 05, 2026

What sparked AbCellera Biologics to soar over 9% after hours - MSN

Apr 05, 2026

Apr 03, 2026